Pharmaceutical Investing

Aptinyx Begins Two Phase 2 Studies of NYX-2925

Biotech Investing

Aravive and AstreZeneca Begin Phase 1/2 Study of AVB-500

Biotech Investing

5 Top NASDAQ Biotech and Pharma Stocks: 65 Percent Rise for Clovis

Biotech Investing

Celgene Receives FDA Approval for REBLOZYL

Biotech Investing

Life Science Big News Roundup: NanoSphere Provides Update on Canadian Operations; RAMM Pharma Commences Trading on the CSE

Life Science Investing

Ovid Therapeutics Reports Q3 Financial Results

Biotech Investing

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Cannabis Investing News

RAMM Pharma Corp. Commences Trading on the CSE Under Ticker Symbol “RAMM”

Cannabis Investing News

Allena Pharma Tumbles on Positive Study Results

Pharmaceutical Investing

Relevium Technologies Appoints Mark Billings as Chief Financial Officer

Cannabis Investing News

Crescita Gets FDA Approval for Enhanced Formulation of Pliaglis

Pharmaceutical Investing

Harvest One Provides Satipharm CBD Gelpell® Update

Cannabis Investing News

Latest pharmaceutical News

More pharmaceutical News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES